Intercept is a biopharmaceutical company focused on building a healthier tomorrow for people with progressive non-viral liver diseases.
The 2024 Intercept Educational Grants program is for U.S. organizations only and will begin accepting grant proposals December 4, 2023.
Healthcare Professional Education:
-
Information needed for submittal of 2024
Educational Grants:
- Grant application and Budget form (Download forms from this site)
- Letter of Request on organization’s letterhead
- Program agenda / brochure
- Completed W-9 Form
- Submit all completed documents to grants@interceptpharma.com
- Education Grants may be awarded to accredited education providers and/or independent third-party Healthcare Education companies that develop and administer programs designed to meet the education needs of healthcare professionals including physicians, nurse practitioners, physician assistants, pharmacists, nurses, and research scientists or others working in the fields of Hepatology and/or Gastroenterology
- Grant recipients are responsible for the content, quality, scientific integrity, and adherence to ACCME Standards for Commercial Support of all activities they certify for accreditation
CURRENT AREAS OF INTEREST
Primary Biliary Cholangitis (PBC), depending on educational needs assessment(s):
- The effect/impact of PBC treatment(s) on clinical outcomes
- Importance of the appropriate and timely initiation of first- and second-line treatment and factors that lead to low rates of initiation of PBC treatments, with intent to resolve contributory barriers and inequities in access to PBC treatments and specialist GI/Hep care through HCP education
- Importance of routinely/closely monitoring ALP as well as a broader range of biomarkers beyond ALP (i.e., ALT, AST, total bilirubin, GGT and liver fibrosis) to inform timely initiation of second-line treatment in order to reduce likelihood of disease progression
- Appropriate management of pruritus associated with PBC
- Real-world evidence related to PBC natural history, diagnosis, disease management, and clinical outcomes on or off appropriate treatments for PBC
Program Parameters to consider for 2024 applications:
- Intercept is currently prioritizing national and virtual programs with enduring Certified Medical Education material(s)
- Advanced practice provider inclusion is encouraged
- 2-year education certification is preferred
- All grant proposals should incorporate plans to measure learner progress with a Moore’s rating of ≥ 4
- Please ensure your educational grant proposal is submitted a minimum of 90 days prior to commencement of the activity.